Clinical Trials Logo

Vasospasm, Intracranial clinical trials

View clinical trials related to Vasospasm, Intracranial.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT02907879 Terminated - Clinical trials for Subarachnoid Hemorrhage

Contrast Enhanced Ultrasound Imaging for Cerebral Perfusion Measurement in Cerebral Vasospasm After SAH

Start date: July 2013
Phase:
Study type: Observational

The objective of the study is to assess brain tissue perfusion by ultrasound perfusion imaging. Specifically - to diagnose brain tissue hypoperfusion due to CVS with contrast enhanced UPI and to assess specificity and sensitivity, and predictive values for detection of brain tissue hypoperfusion leading to infarction - to test whether treatment-effects by induced hypertension, balloon-dilatation, or intra-arterial nimodipine infusion can be detected and quantified by UPI

NCT ID: NCT02712788 Terminated - Cerebral Vasospasm Clinical Trials

Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Start date: April 18, 2016
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the usefulness of adding Milrinone to the current standard treatment for cerebral vasospasm.

NCT ID: NCT02176837 Terminated - Clinical trials for Subarachnoid Hemorrhage

Intravenous Nitrite Infusion for Reversal of Cerebral Vasospasm After Subarachnoid Hemorrhage

Start date: June 2014
Phase: Phase 2
Study type: Interventional

The hypothesis is that intravenous infusion of sodium nitrite is safe and effective for the reversal of cerebral vasospasm after subarachnoid hemorrhage in patients with a cerebral aneurysm.

NCT ID: NCT01845441 Terminated - Stroke Clinical Trials

Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions

Start date: April 2012
Phase: Phase 2
Study type: Interventional

Dexmedetomidine is a unique sedative medication able to provide sedation without causing respiratory depression and maintaining neurological functions. Patients having an acute ischemic stroke and need to undergo endovascular therapy require constant assessment of their neurological status prior, during and after the interventional procedure. In this study the investigators will compare the efficacy of Dexmedetomidine to other standard sedative medications in providing optimal sedative effect while maintaining neurological function.

NCT ID: NCT01810302 Terminated - Cerebral Vasospasm Clinical Trials

Safety Study of Nicardipine to Treat Cerebral Vasospasm

Start date: August 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if intrathecal nicardipine is safe for the treatment of cerebral vasospasm.

NCT ID: NCT01407614 Terminated - Brain Ischemia Clinical Trials

The Tilburg Vasospasm Study

Start date: December 2007
Phase: Phase 2/Phase 3
Study type: Interventional

In a prospective randomized controlled trial, the investigators aim to assess whether external lumbar drainage (ELD) of CSF is safe and reduces delayed cerebral ischemia and its sequelae in patients with an aneurysmal subarachnoid hemorrhage.

NCT ID: NCT01343537 Terminated - Aneurysm Clinical Trials

Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects

Start date: December 2010
Phase: Phase 0
Study type: Interventional

Aneurysmal subarachnoid hemorrhage (bleeding on the brain due to a ruptured aneurysm) is a serious condition with a high morbidity (incidence of having ill health) and mortality (death). There are approximately 11 cases per 100,000 in the population per year, and approximately 40% of these cases are fatal. (Ingall) Among the fortunate subjects who survive the initial bleed, vasospasm and subsequent stroke are a major cause of morbidity. Vasospasm is defined as a prolonged severe, although reversible cause of arterial narrowing that occurs after bleeding into the subarachnoid space, most commonly after aneurysmal rupture. (Youman) The reduced arterial diameter inhibits blood flow and deprives the brain of oxygen, which often results in a stroke. Vasospasm is a major problem when treating subjects with aneurysmal subarachnoid hemorrhage. For these reasons, it is essential to diagnose cerebral vasospasm early, before permanent deficits develop. There may be another option to solve this dilemma. The field of neuro-monitoring (neurological monitoring) has the technology available to continuously monitor brain activity of these sedated ICU subjects. This may allow for early diagnosis and possibly identify changes in neurologic function before they become symptomatic. In the past, neuro-monitoring was primarily used in the operating room to monitor neurologic function during surgery in and around the spinal cord. Surgery to the spine or spinal cord also carries its own form of risk, either from mechanical trauma to the spinal cord or its nerve roots, or from interruption of the blood supply to these structures. Should damage to nerve fibers occur, the end result could be paralysis, loss of sensation, and onset of severe burning (i.e. neuropathic) pain. The field of intraoperative neuro-monitoring (IOM) was developed to address these risks during spine surgery, whereby nerves rostral (toward the head) or caudal (toward the feet) to the site of surgery are stimulated (usually via electrical pulses) and signals are recorded from the side opposite to the site of stimulation. Thus, the signals carried by nerve fibers are forced to pass through the region at risk from the surgery. In the event that changes in nerve responses are seen, the surgical team is notified, and they can change what they're doing to try and restore signals, thereby preserving function in the nerve fibers. This same technology has been used in the neurosurgical ICU to monitor subjects with severe brain injury from trauma, stroke, intracranial hemorrhage and subarachnoid hemorrhage. Using continuous electroencephalogram (EEG) monitoring combined with somatosensory evoked potentials (SSEPs) (a type of neuro monitoring) has been used to determine prognosis, identify subjects in subclinical status epilepticus (state of brain being in a constant seizure), predict elevations in the intracranial pressure Increased pressure within the skull), and diagnose cerebral hypoxia (not enough oxygen in the brain) (Amantini)

NCT ID: NCT00930072 Terminated - Vasospasm Clinical Trials

Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Start date: April 2009
Phase: Phase 2
Study type: Interventional

To evaluate the feasibility of performing a cervical sympathetic block in patients with severe cerebral vasospasm involving the anterior cerebral circulation following aneurysmal SAH.

NCT ID: NCT00585559 Terminated - Clinical trials for Aneurysmal Subarachnoid Hemorrhage

Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm

Start date: April 2007
Phase: Phase 3
Study type: Interventional

The objective of this study is to determine whether acetaminophen (APAP), N-acetylcysteine (NAC), and APAP in combination with NAC will inhibit lipid peroxidation in aneurysmal subarachnoid hemorrhage (aSAH), utilizing F2-IsoPs as biomarkers for lipid peroxidation.

NCT ID: NCT00582868 Terminated - Clinical trials for Subarachnoid Hemorrhage

Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH

Start date: May 2007
Phase: N/A
Study type: Observational

The purpose of this study is to investigate if brain oxygen levels, levels of a specific protein in the cerebrospinal fluid and blood (Cleaved-tau protein), and brain blood flow can predict spasm of brain blood vessels after bleeding in the brain from a ruptured aneurysm.